Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Sarcolemma
Activated Protein C Resistance
Crown Ethers
Plaque, Atherosclerotic
Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071).
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071).
Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071). Cancer Chemother Pharmacol. 1998; 42(1):84-7.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Area Under Curve
Camptothecin
Female
Humans
Male
Middle Aged
Neoplasms
authors with profiles
Mark J. Ratain
Richard Schilsky
Gini Fleming